Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Prognostic factors for survival in colorectal cancer patients.

Laohavinij S, Maneechavakajorn J, Techatanol P.

J Med Assoc Thai. 2010 Oct;93(10):1156-66.

PMID:
20973318
2.

Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.

Ahmed S, Ahmad I, Zhu T, Arnold FP, Faiz Anan G, Sami A, Yadav SK, Alvi R, Haider K.

Dis Colon Rectum. 2010 Oct;53(10):1432-8. doi: 10.1007/DCR.0b013e3181e78815.

PMID:
20847626
3.

Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.

Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD.

J Am Coll Surg. 2003 May;196(5):722-8.

PMID:
12742204
4.

Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers.

Aslam MI, Kelkar A, Sharpe D, Jameson JS.

Int J Surg. 2010;8(4):305-13. doi: 10.1016/j.ijsu.2010.03.005. Epub 2010 Apr 7.

5.

Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis.

Stelzner S, Hellmich G, Koch R, Ludwig K.

J Surg Oncol. 2005 Mar 15;89(4):211-7.

PMID:
15726622
6.
7.

Retrospective long-term results and prognostic factors of postoperative treatment for UICC stages II and III rectal cancer.

Genovesi D, Cèfaro GA, Vinciguerra A, Augurio A, D'Alessandro M, Borzillo V, Marchese R, Di Nicola M.

Tumori. 2009 Nov-Dec;95(6):675-82.

8.

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Dis Colon Rectum. 2008 May;51(5):503-7. doi: 10.1007/s10350-008-9246-z. Epub 2008 Mar 6.

PMID:
18322753
9.

Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.

Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.

Cancer. 1998 Jan 1;82(1):49-59.

PMID:
9428479
10.

Are survival rates different for young and older patients with rectal cancer?

O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY.

Dis Colon Rectum. 2004 Dec;47(12):2064-9.

PMID:
15657655
11.

Independently predictive prognostic variables after resection for colorectal carcinoma.

Payne JE, Meyer HJ.

Aust N Z J Surg. 1997 Dec;67(12):849-53.

PMID:
9451339
12.

[Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].

Wang Y, Zhao P, Wang CF, Shan Y, Zhao DB, Tian YT, Sun YM, Che X, Zhang JW.

Zhonghua Yi Xue Za Zhi. 2009 Sep 15;89(34):2381-5. Chinese.

PMID:
20137689
13.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

PMID:
15708244
14.

Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.

Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T, Kodaira S, Kato T, Ogawa N.

Cancer. 1996 Aug 1;78(3):403-8.

15.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
16.

Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.

Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.

Southeast Asian J Trop Med Public Health. 2005 Jul;36(4):994-1006.

PMID:
16295558
17.

Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.

Law WL, Ho JW, Chan R, Au G, Chu KW.

Dis Colon Rectum. 2005 Feb;48(2):218-26.

PMID:
15711860
18.

Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.

Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.

Colorectal Dis. 2008 Jul;10(6):563-8. Epub 2007 Dec 7.

PMID:
18070184
19.

The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.

Luna-Pérez P, Reyna Huelga A, Labastida Almendaro S, Rodríguez-Coria DF, González Macouzet J, Delgado Gallardo S.

Rev Invest Clin. 1999 Jul-Aug;51(4):205-13.

PMID:
10546501
20.

Prognostic value of perineural invasion in patients with stage II colorectal cancer.

Huh JW, Kim HR, Kim YJ.

Ann Surg Oncol. 2010 Aug;17(8):2066-72. doi: 10.1245/s10434-010-0982-7. Epub 2010 Feb 25.

PMID:
20182809

Supplemental Content

Support Center